The importance of bioregulatory therapy in the treatment of rhinosinusitis
A.Yu. Ovchinnikov, N.A. Miroshnichenko, I.V. Smirnov
A.I. Yevdokimov Moscow State University of Medicine and Dentistry
Rhinosinusitis is one of the most common diseases that affects people regardless of their age, social status and place of living. Infection enters the body through the upper respiratory tract, the entrance gate is mainly the nasal mucous membrane. In the case of long-term acute inflammation, complications can develop with the formation of chronic processes: irreversible changes in the mucous membrane of the nasal cavity and paranasal sinuses, bacterial inflammation, persistent swelling of the mucous membrane. Therefore, it is advisable to conduct timely not only symptomatic, but also anti-inflammatory and antimicrobial therapy of rhinosinusite. The article shows the effectiveness of the nasal spray Euphorbium compositum® Nazentropfen C in the treatment of rhinosinusitis. This drug can be recommended for the treatment of various forms of rhinosinusitis. Studies of the use of Euphorbium compositum® have shown a multi-purpose mechanism of drug action. Euphorbium compositum® maintains mucous membrane function due to its antiviral and anti-inflammatory properties. To achieve the best results, the drug should be used at the first signs of starting rhinosinusitis.
Keywords: rhinosinusitis, antimicrobial therapy, symptomatic systemic therapy, bioregulatory medicine, Euphorbium compositum.
For citation: Ovchinnikov A.Yu., Miroshnichenko N.A., Smirnov I.V. The importance of bioregulatory therapy in the treatment of rhinosinusitis. RMJ. Medical Review. 2019;2(II):51–53.
References
1. Тарасова Г.Д., Лавренова Г.В., Куликова О.А. и др. Вирусные заболевания ЛОР-органов. Folia Otorhinolaryngologiae et pathologiae respiratoriae. 2017;23(1):25–33. [Tarasova G.D., Lavrenova G.V., Kulikova O.A. et al. Viral diseases of ENT organs. Folia Otorhinolaryngologiae et pathologia respiratoriae. 2017;23(1):25–33 (in Russ.)].
2. ОРВИ и грипп: в помощь практикующему врачу / Под ред. Е.П. Сельникова, О.В. Калюжина. М.: Медицинское информационное агентство, 2015. [ARVI and flu: to help the practitioner / Ed. E.P. Selnikov, O.V. Kaluzhina. M.: Medical Information Agency, 2015 (in Russ.)].
3. Rosenfeld R.M., Andes D., Bhattacharyya N. et al. Clinical practice guideline: adult sinusitis. Otolaryngol. Head Neck Surg. 2007;137(3 suppl.):1– 31.
4. Wallace D.V., Dykewicz M.S., Bernstein D.I. et al. The diagnosis and management of rhinitis: an updated practice parameter. J. Allergy Clin. Immunol. 2008;122(2 suppl.):1–84.
5. Willsie S.K. Improved strategies and new treatment options for allergic rhinitis. J. Am. Osteopath. Assoc. 2002;102(6, suppl. 2):7–14.
6. Gottwald R., Weiser M. Antihomotoxic Treatment of Agitation with and without Fever in Children; The results of a post-marketing clinical study. International Journal for Biomedical Research and Therapy. 1999;28(6):308–312.
7. Raab V. Practice report. Further therapeutic experience with Euphorbium compositum nasal drops (metered dose spray without propellant gas) in ENT practice. Biologische Medizin. 1982;4:176–179.
8. Schmolz M., Metelmann H. Modulation of cytokine synthesis in human leukocytes by individual components of a combination homeopathic nasal spray. Biol. Therapy. 1999;17(2):61–63.
9. Glatthaar-Saalmüller B., Fallier-Becker P. Antiviral action of Euphorbium compostitum and its components. Forsch Komplementarmed Klass Naturheilkd. 2001;8(4):207–212.
10. Ammerschläger H., Klein P., Weiser M., Oberbaum M. Treatment of inflammatory diseases of the upper respiratory tract — comparison of a homeopathic complex remedy with xylometazoline. Forsch Komplementärmed Klass Naturheilkd. 2005;12:24–31.
11. Черняк Б.А., Носуля Е.В., Секретарева Л.Б., Ким Е.А. Влияние продолжительности терапии назальными КС на ее эффективность при полипозном риносинусите. Пульмонология. 2005;2:107–112. [Chernyak B.A., Nosulya E.V., Sekretareva L.B., Kim E.A. The effect of the duration of nasal CS therapy on its efficacy in polypous rhinosinusitis. Pulmonology. 2005;2:107–112 (in Russ.)].
12. Glatthaar-Saalmüller B., Borner M., Weiser M. Euphorbium compositum: viruses of the upper respiratory tract inhibited. Biologische Medizin. 2002;4:194–195.
2. ОРВИ и грипп: в помощь практикующему врачу / Под ред. Е.П. Сельникова, О.В. Калюжина. М.: Медицинское информационное агентство, 2015. [ARVI and flu: to help the practitioner / Ed. E.P. Selnikov, O.V. Kaluzhina. M.: Medical Information Agency, 2015 (in Russ.)].
3. Rosenfeld R.M., Andes D., Bhattacharyya N. et al. Clinical practice guideline: adult sinusitis. Otolaryngol. Head Neck Surg. 2007;137(3 suppl.):1– 31.
4. Wallace D.V., Dykewicz M.S., Bernstein D.I. et al. The diagnosis and management of rhinitis: an updated practice parameter. J. Allergy Clin. Immunol. 2008;122(2 suppl.):1–84.
5. Willsie S.K. Improved strategies and new treatment options for allergic rhinitis. J. Am. Osteopath. Assoc. 2002;102(6, suppl. 2):7–14.
6. Gottwald R., Weiser M. Antihomotoxic Treatment of Agitation with and without Fever in Children; The results of a post-marketing clinical study. International Journal for Biomedical Research and Therapy. 1999;28(6):308–312.
7. Raab V. Practice report. Further therapeutic experience with Euphorbium compositum nasal drops (metered dose spray without propellant gas) in ENT practice. Biologische Medizin. 1982;4:176–179.
8. Schmolz M., Metelmann H. Modulation of cytokine synthesis in human leukocytes by individual components of a combination homeopathic nasal spray. Biol. Therapy. 1999;17(2):61–63.
9. Glatthaar-Saalmüller B., Fallier-Becker P. Antiviral action of Euphorbium compostitum and its components. Forsch Komplementarmed Klass Naturheilkd. 2001;8(4):207–212.
10. Ammerschläger H., Klein P., Weiser M., Oberbaum M. Treatment of inflammatory diseases of the upper respiratory tract — comparison of a homeopathic complex remedy with xylometazoline. Forsch Komplementärmed Klass Naturheilkd. 2005;12:24–31.
11. Черняк Б.А., Носуля Е.В., Секретарева Л.Б., Ким Е.А. Влияние продолжительности терапии назальными КС на ее эффективность при полипозном риносинусите. Пульмонология. 2005;2:107–112. [Chernyak B.A., Nosulya E.V., Sekretareva L.B., Kim E.A. The effect of the duration of nasal CS therapy on its efficacy in polypous rhinosinusitis. Pulmonology. 2005;2:107–112 (in Russ.)].
12. Glatthaar-Saalmüller B., Borner M., Weiser M. Euphorbium compositum: viruses of the upper respiratory tract inhibited. Biologische Medizin. 2002;4:194–195.
This work is licensed under a Creative Commons «Attribution» 4.0 License.
Previous article
Next article
